BioCentury | Aug 3, 2017
Translation in Brief

New Therapeutic Targets and Biomarkers: July 2017

...cancer; melanoma Oncogenic RAS-induced lncRNA 1 (ORILNC1) Cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) ORILNC1...
BioCentury | Jul 18, 2017
Distillery Therapeutics

Cancer

...Breast cancer; melanoma Cell culture and mouse studies suggest inhibiting the long non-coding RNA (lncRNA) ORILNC1...
...and BRAF -driven melanoma. In KRAS-mutant breast cancer and BRAF-mutant melanoma cell lines, shRNA targeting ORILNC1...
...Next steps could include inhibiting ORILNC1 in other models of breast cancer and melanoma. TARGET/MARKER/PATHWAY: Oncogenic RAS-induced lncRNA 1 (ORILNC1)...
Items per page:
1 - 2 of 2